1-8 of 8
Authors: Philippe Morlat
Save search
Sort by
Journal Article

Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study

PDF
Laurent Mandelbrot and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 7, July 2023, Pages 1711–1722, https://doi.org/10.1093/jac/dkad161
Published: 30 May 2023
Journal Article

Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance

PDF
Sidonie Lambert-Niclot and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1510–1521, https://doi.org/10.1093/jac/dkad119
Published: 27 April 2023
Journal Article

Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial

PDF
Antoine Chéret and others
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 9, September 2022, Pages 2506–2515, https://doi.org/10.1093/jac/dkac207
Published: 28 June 2022
Journal Article

Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial

PDF
Claire Pressiat and others
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 4, April 2018, Pages 1020–1024, https://doi.org/10.1093/jac/dkx498
Published: 22 January 2018
Journal Article

High decay of blood HIV reservoir when tenofovir/emtricitabine/elvitegravir/cobicistat is initiated during the acute primary HIV infection

PDF
Elisabeth Carolle Ngo Bell and others
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 9, September 2017, Pages 2681–2683, https://doi.org/10.1093/jac/dkx166
Published: 05 June 2017
Journal Article

Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART

PDF
S. Lambert-Niclot and others
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 4, April 2016, Pages 1056–1062, https://doi.org/10.1093/jac/dkv427
Published: 24 December 2015
Journal Article

Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial) Get access

PDF
Sébastien Gallien and others
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 1, January 2011, Pages 184–191, https://doi.org/10.1093/jac/dkq395
Published: 28 October 2010
Journal Article

HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens Get access

PDF
Daniel da Silva and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 6, June 2010, Pages 1262–1269, https://doi.org/10.1093/jac/dkq099
Published: 12 April 2010